Tandem Diabetes Stock Forecast - Accumulation Distribution
| TNDM Stock | USD 30.63 0.59 1.89% |
Tandem Stock Forecast is based on your current time horizon. Although Tandem Diabetes' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Tandem Diabetes' systematic risk associated with finding meaningful patterns of Tandem Diabetes fundamentals over time.
Tandem |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 26094.16 | 13436.77 |
| Check Tandem Diabetes Volatility | Backtest Tandem Diabetes | Trend Details |
Tandem Diabetes Trading Date Momentum
| On October 17 2024 Tandem Diabetes Care was traded for 34.81 at the closing time. The top price for the day was 37.64 and the lowest listed price was 34.09 . The trading volume for the day was 1.8 M. The trading history from October 17, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 7.17% . The trading price change against the current closing price is 6.21% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Tandem Diabetes to competition |
Other Forecasting Options for Tandem Diabetes
For every potential investor in Tandem, whether a beginner or expert, Tandem Diabetes' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Tandem Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Tandem. Basic forecasting techniques help filter out the noise by identifying Tandem Diabetes' price trends.Tandem Diabetes Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tandem Diabetes stock to make a market-neutral strategy. Peer analysis of Tandem Diabetes could also be used in its relative valuation, which is a method of valuing Tandem Diabetes by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Tandem Diabetes Care Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Tandem Diabetes' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Tandem Diabetes' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Tandem Diabetes Market Strength Events
Market strength indicators help investors to evaluate how Tandem Diabetes stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Tandem Diabetes shares will generate the highest return on investment. By undertsting and applying Tandem Diabetes stock market strength indicators, traders can identify Tandem Diabetes Care entry and exit signals to maximize returns.
Tandem Diabetes Risk Indicators
The analysis of Tandem Diabetes' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Tandem Diabetes' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting tandem stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.4 | |||
| Standard Deviation | 3.1 | |||
| Variance | 9.63 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Tandem Diabetes to cross-verify your projections. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tandem Diabetes. If investors know Tandem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tandem Diabetes listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.37) | Earnings Share (1.94) | Revenue Per Share 13.082 | Quarterly Revenue Growth 0.314 | Return On Assets (0.1) |
The market value of Tandem Diabetes Care is measured differently than its book value, which is the value of Tandem that is recorded on the company's balance sheet. Investors also form their own opinion of Tandem Diabetes' value that differs from its market value or its book value, called intrinsic value, which is Tandem Diabetes' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tandem Diabetes' market value can be influenced by many factors that don't directly affect Tandem Diabetes' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tandem Diabetes' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tandem Diabetes is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tandem Diabetes' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.